Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets

Full text
Author(s):
dos Santos Fernandes, Guilherme Felipe [1] ; Jornada, Daniela Hartmann [1] ; de Souza, Paula Carolina [1] ; Chin, Chung Man [1] ; Pavan, Fernando Rogerio [1] ; dos Santos, Jean Leandro [1]
Total Authors: 6
Affiliation:
[1] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Araraquara - Brazil
Total Affiliations: 1
Document type: Journal article
Source: Current Medicinal Chemistry; v. 22, n. 27, p. 3133-3161, 2015.
Web of Science Citations: 7
Abstract

Tuberculosis (TB) is an infectious disease caused by bacterium of the Mycobacterium genus, mainly by Mycobacterium tuberculosis (MTB). The World Health Organization aims to substantially reduce the number of cases in the coming years; however, the increased number of multidrug-resistant (MDR) and extremely drug-resistant (XDR) forms of the bacterium and the lack of treatment for latent tuberculosis are challenges to be overcome. In this review, we have identified the most potent compounds described in the literature during recent years with MIC values <7 mu M, low toxicity and a high selective index. In addition, emerging targets in MTB are presented to provide new perspectives for the discovery of new antitubercular drugs. This review aims to summarize the current advances in and promote insights into antitubercular drug discovery. (AU)

FAPESP's process: 14/24811-0 - Design and synthesis of new 1,4-di-N-oxide quinoxaline as antitubercular compounds to treat multi drug-resistant (MDR) and latent tuberculosis
Grantee:Guilherme Felipe dos Santos Fernandes
Support Opportunities: Scholarships abroad - Research Internship - Master's degree
FAPESP's process: 14/02240-1 - Design, Synthesis and anti Mycobacterium tuberculosis activity of new N-oxides derivatives
Grantee:Guilherme Felipe dos Santos Fernandes
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 13/14957-5 - Research potential against tuberculosis of a new class of furoxan compounds and nanostructured compounds of the ruthenium(II) and copper (II)
Grantee:Fernando Rogério Pavan
Support Opportunities: Research Grants - Young Investigators Grants